This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Council of Europe (1997) Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine
Council of Europe, Steering Committee on Bioethics (2003) Draft Additional Protocol to the Convention on Human Rights and Biomedicine, on Biomedical Research.
Djulbegovic B, Lacevic D, Cantor A et al. (2000) The uncertainty principle and industry-sponsored research. Lancet 365:635–638
Grady C (2002) Ethical principles in clinical research. In: Gallin JI (Ed.) Principles and practice of clinical research. Academic Press, San Diego, P 15–26
Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7–22
Levitan HL (1981) Patterns of hostility revealed in the fantasies and dreams of women with rheumatoid arthritis. Psychotherapy and Psychosomatics 35:34–43
Melander H, Ahlquist-Rastad J, Meijer G, Beermann B (2003) Evidence b(i)ased medicine — selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326:1171–1173
Riggs LB, Hodgson SB, O’Fallon M et al. (1990) Effect of Fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. New England Journal of Medicine 322:802–809
Royal College of Paediatrics and Child Health (2000) Ethics Advisory Committee: Guidelines for the ethical conduct of medical research involving children. Archives of Disease in Childhood 82:177–182
Sackett D, Haynes RB (2002) Evidence base of clinical diagnosis. The architecture of diagnostic research. BMJ 324:539–541
Scandinavian Simvastatin Survival Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344: 1383–1389
Shepherd J, Cobbe SM, Ford I et al. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New England Journal of Medicine 333:1301–1307
Shepherd J, Blauw GJ, Murphy MB et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360:1623–1630
The European Parliament and the Council (2001) Directive on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities 121:34–44
The West of Scotland Coronary Prevention Study Group (1992) A coronary primary prevention study of Scottish men aged 45-64 years: trial design. Journal of Clinical Epidemiology 45:849–860
Wells G, Beaton D, Shea B et al. (2001) Minimal clinically important differences: Review of methods. Journal of Rheumatology 28: 406–412
World Medical Association Declaration of Helsinki (2002) Ethical Principles for Medical Research Involving Human Subjects. WMA, Washington
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Raspe, H. (2005). Clinical Evaluative Research: Which Patients Benefit, How and When? A Contribution to a European Discussion. In: ter Meulen, R., Biller-Andorno, N., Lenk, C., Lie, R.K. (eds) Evidence-based Practice in Medicine and Health Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27133-3_12
Download citation
DOI: https://doi.org/10.1007/3-540-27133-3_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22239-2
Online ISBN: 978-3-540-27133-8
eBook Packages: MedicineMedicine (R0)